Shires Courtney B, Latour Mackenzie, Sebelik Merry, Dewan Karuna
West Cancer Center Germantown Tennessee USA.
Department of Otolaryngology-Head and Neck Surgery Louisiana State University Health Shreveport Shreveport Louisiana USA.
World J Otorhinolaryngol Head Neck Surg. 2024 Jan 5;10(1):43-48. doi: 10.1002/wjo2.155. eCollection 2024 Mar.
Pharyngocutaneous fistula (PCF) is the most common complication to follow total laryngectomy (TL) and is associated with increases in length of hospital stay and with a need for revision surgery or readmission, as well as with delays in return to oral diet. Patients who require salvage TL (STL) or primary (chemo)radiation therapy are at higher risk for developing PCF. Due to the quality-of-life burden of PCF on patients, limiting this occurrence is crucial.
We conducted a retrospective cohort study of patients undergoing STL with placement of Montgomery salivary bypass tube (MSBT)™ for at least 2 weeks duration between 2013 and 2017 at a single institution. Our patients all underwent free flap reconstruction. Our primary outcome of interest was development of PCF. Secondary outcomes included demographics, previous treatment, base of tongue (BOT) involvement, extent of defect, concurrent neck dissection (ND), and margin status. Univariate analysis was used to evaluate factors associated with PCF.
Forty-four patients underwent STL with Montgomery tube placement and free flap reconstruction. Eight developed PCF (18.2%). The average age was 61.6 years; 36 patients were male (81.8%), whereas eight patients were female (18.2%). There was no association between PCF and previous chemoradiation versus radiation (15.8% vs. 33.3%, < 0.30), BOT involvement versus not (11.1 vs. 22.2%, < 0.38), circumferential versus partial defect (18.8% vs. 17.9%, < 0.94), ND versus none (10% vs. 25%, < 0.20), or margin status.
PCF complicated 18.2% of STL cases at our institution and was not associated with differences in primary treatment modality, presence of concomitant ND, extent of pharyngeal defect, BOT involvement, or positive frozen or permanent surgical margin.
咽皮肤瘘(PCF)是全喉切除术(TL)后最常见的并发症,与住院时间延长、需要进行修复手术或再次入院以及恢复经口饮食延迟有关。需要挽救性全喉切除术(STL)或接受初次(化疗)放疗的患者发生PCF的风险更高。由于PCF给患者带来生活质量负担,限制其发生至关重要。
我们对2013年至2017年在单一机构接受STL并放置蒙哥马利唾液转流管(MSBT)™至少2周的患者进行了一项回顾性队列研究。我们的患者均接受了游离皮瓣重建。我们感兴趣的主要结局是PCF的发生。次要结局包括人口统计学特征、既往治疗、舌根(BOT)受累情况、缺损范围、同期颈清扫术(ND)以及切缘状态。采用单因素分析评估与PCF相关的因素。
44例患者接受了STL并放置蒙哥马利管及游离皮瓣重建。8例发生了PCF(18.2%)。平均年龄为61.6岁;36例患者为男性(81.8%),8例患者为女性(18.2%)。PCF与既往放化疗与单纯放疗(15.8%对33.3%,P<0.30)、BOT受累与否(11.1%对22.2%,P<0.38)、环形缺损与部分缺损(18.8%对17.9%,P<0.94)、ND与否(10%对25%,P<0.20)或切缘状态均无关联。
在我们机构,PCF在18.2%的STL病例中发生并发症,且与初始治疗方式的差异、同期ND的存在、咽缺损范围、BOT受累情况或冰冻或永久手术切缘阳性无关。